Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The tissue factor pathway of blood coagulation

Y Nemerson1

  • 1Department of Medicine, Mount Sinai School of Medicine, City University of New York, NY 10029.

Seminars in Hematology
|July 1, 1992
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

My life with tissue factor.

Journal of thrombosis and haemostasis : JTH·2006
Same author

Identification and characterization of murine alternatively spliced tissue factor.

Journal of thrombosis and haemostasis : JTH·2006
Same author

Inhibition of tissue factor limits the growth of venous thrombus in the rabbit.

Journal of thrombosis and haemostasis : JTH·2003
Same author

The TF:VIIa complex: clinical significance, structure-function relationships and its role in signaling and metastasis.

Thrombosis and haemostasis·2001
Same author

Tissue factor, the blood, and the arterial wall.

Trends in cardiovascular medicine·2001
Same author

Tissue factor on the loose.

Seminars in thrombosis and hemostasis·2000
Same journal

Pain in SCD-Many mechanisms and mysteries.

Seminars in hematology·2026
Same journal

The many facets of cardiopulmonary complications in sickle cell disease.

Seminars in hematology·2026
Same journal

Clonal hematopoiesis in the setting of sickle cell disease and its relevance to curative therapies.

Seminars in hematology·2026
Same journal

Treatment of myeloproliferative neoplasms: Exploring new horizons of who and when to cytoreduce in patients with polycythemia vera and essential thrombocytosis.

Seminars in hematology·2026
Same journal

Telomeres biology disorders: the past, the present and the future.

Seminars in hematology·2026
Same journal

Cardiovascular complications in patients with myeloproliferative neoplasms: What hematologists need to know.

Seminars in hematology·2026
See all related articles